Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

JP Neoptolemos; MJ Moore; TF Cox; JW Valle; DH Palmer; AC McDonald; R Carter; NC Tebbutt; C Dervenis; D Smith; B Glimelius; RM Charnley; F Lacaine; Scarfe Ag; MR Middleton; A Anthoney; P Ghaneh; CM Halloran; MM Lerch; A Olah; CL Rawcliffe; CS Verbeke; F Campbell; MW Buchler

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

JP Neoptolemos, MJ Moore, TF Cox, JW Valle, DH Palmer, AC McDonald, R Carter, NC Tebbutt, C Dervenis, D Smith, B Glimelius, RM Charnley, F Lacaine, Scarfe Ag, MR Middleton, A Anthoney, P Ghaneh, CM Halloran, MM Lerch, A OlahCL Rawcliffe, CS Verbeke, F Campbell, MW Buchler

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	147-156
Number of pages	9
Journal	JAMA Internal Medicine
Volume	308
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Neoptolemos, JP., Moore, MJ., Cox, TF., Valle, JW., Palmer, DH., McDonald, AC., Carter, R., Tebbutt, NC., Dervenis, C., Smith, D., Glimelius, B., Charnley, RM., Lacaine, F., Ag, S., Middleton, MR., Anthoney, A., Ghaneh, P., Halloran, CM., Lerch, MM., ... Buchler, MW. (2012). Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA Internal Medicine, 308, 147-156.

@article{ddd6cb1563a746caae5e4ac8e7000bee,

title = "Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial",

author = "JP Neoptolemos and MJ Moore and TF Cox and JW Valle and DH Palmer and AC McDonald and R Carter and NC Tebbutt and C Dervenis and D Smith and B Glimelius and RM Charnley and F Lacaine and Scarfe Ag and MR Middleton and A Anthoney and P Ghaneh and CM Halloran and MM Lerch and A Olah and CL Rawcliffe and CS Verbeke and F Campbell and MW Buchler",

year = "2012",

language = "English",

volume = "308",

pages = "147--156",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

}

Neoptolemos, JP, Moore, MJ, Cox, TF, Valle, JW, Palmer, DH, McDonald, AC, Carter, R, Tebbutt, NC, Dervenis, C, Smith, D, Glimelius, B, Charnley, RM, Lacaine, F, Ag, S, Middleton, MR, Anthoney, A, Ghaneh, P, Halloran, CM, Lerch, MM, Olah, A, Rawcliffe, CL, Verbeke, CS, Campbell, F & Buchler, MW 2012, 'Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial', JAMA Internal Medicine, vol. 308, pp. 147-156.

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. / Neoptolemos, JP; Moore, MJ; Cox, TF et al.
In: JAMA Internal Medicine, Vol. 308, 2012, p. 147-156.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

AU - Neoptolemos, JP

AU - Moore, MJ

AU - Cox, TF

AU - Valle, JW

AU - Palmer, DH

AU - McDonald, AC

AU - Carter, R

AU - Tebbutt, NC

AU - Dervenis, C

AU - Smith, D

AU - Glimelius, B

AU - Charnley, RM

AU - Lacaine, F

AU - Ag, Scarfe

AU - Middleton, MR

AU - Anthoney, A

AU - Ghaneh, P

AU - Halloran, CM

AU - Lerch, MM

AU - Olah, A

AU - Rawcliffe, CL

AU - Verbeke, CS

AU - Campbell, F

AU - Buchler, MW

PY - 2012

Y1 - 2012

M3 - Article

SN - 2168-6106

VL - 308

SP - 147

EP - 156

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

ER -